Northern Trust’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.74M | Buy |
262,211
+177,761
| +210% | +$2.53M | ﹤0.01% | 2634 |
|
2025
Q1 | $1.1M | Sell |
84,450
-2,507
| -3% | -$32.5K | ﹤0.01% | 3240 |
|
2024
Q4 | $1.16M | Buy |
86,957
+22,827
| +36% | +$304K | ﹤0.01% | 3328 |
|
2024
Q3 | $385K | Buy |
64,130
+4,281
| +7% | +$25.7K | ﹤0.01% | 3656 |
|
2024
Q2 | $197K | Sell |
59,849
-1,281
| -2% | -$4.21K | ﹤0.01% | 3873 |
|
2024
Q1 | $229K | Sell |
61,130
-3,460
| -5% | -$13K | ﹤0.01% | 3852 |
|
2023
Q4 | $283K | Buy |
64,590
+27,083
| +72% | +$119K | ﹤0.01% | 3751 |
|
2023
Q3 | $156K | Buy |
37,507
+4,564
| +14% | +$19K | ﹤0.01% | 3897 |
|
2023
Q2 | $115K | Sell |
32,943
-147
| -0.4% | -$513 | ﹤0.01% | 3998 |
|
2023
Q1 | $127K | Buy |
33,090
+2,735
| +9% | +$10.5K | ﹤0.01% | 4018 |
|
2022
Q4 | $85.6K | Hold |
30,355
| – | – | ﹤0.01% | 4143 |
|
2022
Q3 | $64K | Hold |
30,355
| – | – | ﹤0.01% | 4255 |
|
2022
Q2 | $80K | Hold |
30,355
| – | – | ﹤0.01% | 4259 |
|
2022
Q1 | $132K | Hold |
30,355
| – | – | ﹤0.01% | 4261 |
|
2021
Q4 | $130K | Hold |
30,355
| – | – | ﹤0.01% | 4343 |
|
2021
Q3 | $153K | Hold |
30,355
| – | – | ﹤0.01% | 4270 |
|
2021
Q2 | $187K | Sell |
30,355
-147,603
| -83% | -$909K | ﹤0.01% | 4182 |
|
2021
Q1 | $1.3M | Sell |
177,958
-5,668
| -3% | -$41.5K | ﹤0.01% | 3471 |
|
2020
Q4 | $1.49M | Buy |
183,626
+17,948
| +11% | +$146K | ﹤0.01% | 3339 |
|
2020
Q3 | $1.31M | Buy |
165,678
+110,238
| +199% | +$872K | ﹤0.01% | 3263 |
|
2020
Q2 | $302K | Buy |
55,440
+34,047
| +159% | +$185K | ﹤0.01% | 3660 |
|
2020
Q1 | $88K | Hold |
21,393
| – | – | ﹤0.01% | 3847 |
|
2019
Q4 | $154K | Hold |
21,393
| – | – | ﹤0.01% | 3853 |
|
2019
Q3 | $135K | Buy |
+21,393
| New | +$135K | ﹤0.01% | 3857 |
|